X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-08 | BCAB | McBrinn Sylvia | Dir | P - Purchase | $2.54 | +2,000 | 11,125 | +22% | +$5,080 | ||||||
2023-03-29 | BCAB | Short Jay M Phd | CEO, 10% | P - Purchase | $2.47 | +40,800 | 3,025,762 | +1% | +$100,862 | ||||||
2023-03-28 | BCAB | Vasquez Christian | See Remarks | P - Purchase | $2.40 | +20,000 | 102,709 | +24% | +$47,970 | ||||||
2022-12-19 | BCAB | McBrinn Sylvia | Dir | P - Purchase | $8.33 | +3,700 | 9,125 | +68% | +$30,813 | ||||||
2022-11-22 | BCAB | McBrinn Sylvia | Dir | P - Purchase | $8.27 | +2,000 | 5,425 | +58% | +$16,540 | ||||||
| M | 2022-09-12 | BCAB | McBrinn Sylvia | Dir | P - Purchase | $8.63 | +3,000 | 3,000 | New | +$25,900 | |||||
2022-08-12 | BCAB | Short Jay M Phd | CEO, 10% | P - Purchase | $7.84 | +26,350 | 3,009,931 | +1% | +$206,600 | ||||||
| M | 2022-06-21 | BCAB | Short Jay M Phd | CEO, 10% | P - Purchase | $2.86 | +69,390 | 2,989,357 | +2% | +$198,336 | |||||
| M | 2022-06-07 | BCAB | Vasquez Christian | See Remarks | P - Purchase | $3.02 | +50,000 | 74,525 | +204% | +$150,914 | |||||
| M | 2021-11-30 | BCAB | Waldron Richard A | CFO | S - Sale | $23.48 | -14,190 | 134,469 | -10% | -$333,148 | |||||
| M | 2021-11-30 | BCAB | Vasquez Christian | See Remarks | S - Sale | $23.48 | -1,979 | 25,259 | -7% | -$46,462 | |||||
| M | 2021-11-30 | BCAB | Smith Scott Andrew | Pres | S - Sale | $22.27 | -4,090 | 345,656 | -1% | -$91,099 | |||||
| M | 2021-11-30 | BCAB | Sievers Eric | Chief Medical Officer | S - Sale | $22.27 | -1,124 | 91,506 | -1% | -$25,035 | |||||
| M | 2021-11-30 | BCAB | Short Jay M Phd | CEO, 10% | S - Sale | $23.48 | -47,622 | 2,934,136 | -2% | -$1,118,046 | |||||
2021-11-29 | BCAB | Waldron Richard A | CFO | S - Sale | $23.89 | -4,599 | 148,659 | -3% | -$109,870 | ||||||
2021-11-29 | BCAB | Vasquez Christian | See Remarks | S - Sale | $23.89 | -642 | 27,238 | -2% | -$15,337 | ||||||
2021-11-29 | BCAB | Smith Scott Andrew | Pres | S - Sale | $23.89 | -399 | 349,746 | 0% | -$9,532 | ||||||
2021-11-29 | BCAB | Sievers Eric | Chief Medical Officer | S - Sale | $23.89 | -110 | 92,630 | 0% | -$2,628 | ||||||
2021-11-29 | BCAB | Short Jay M Phd | CEO, 10% | S - Sale | $23.89 | -15,435 | 2,981,758 | -1% | -$368,742 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |